Dixie‐Lee Esseltine
- Molecular Biology top 10%
- Hematology top 0.5%
- Oncology top 5%
- Genetics top 5%
- Pathology and Forensic Medicine top 10%
- Co-authors
- Paul G. RichardsonJessica AndersonKenneth C. AndersonRobert Z. OrlowskiSagar LonialStephanie StahlBeverly S. MitchellMary Jo Lehman
- Topics
- Multiple Myeloma Research and Treatments (6 papers)Protein Degradation and Inhibitors (4 papers)Viral-associated cancers and disorders (3 papers)
- Cited by
- HematologyOncologyGenetics
- Partner nations
- United StatesFranceSpain
In The Last Decade
Dixie‐Lee Esseltine
12 papers receiving 1.7k citations
Hit Papers
Peers
Comparison fields: 5 of 70
- Molecular Biology 1.2k
- Hematology 1.1k
- Oncology 817
- Genetics 285
- Pathology and Forensic Medicine 190
Countries citing papers authored by Dixie‐Lee Esseltine
This map shows the geographic impact of Dixie‐Lee Esseltine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dixie‐Lee Esseltine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dixie‐Lee Esseltine more than expected).
Fields of papers citing papers by Dixie‐Lee Esseltine
This network shows the impact of papers produced by Dixie‐Lee Esseltine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dixie‐Lee Esseltine. The network helps show where Dixie‐Lee Esseltine may publish in the future.
Co-authorship network of co-authors of Dixie‐Lee Esseltine
This figure shows the co-authorship network connecting the top 25 collaborators of Dixie‐Lee Esseltine. A scholar is included among the top collaborators of Dixie‐Lee Esseltine based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dixie‐Lee Esseltine. Dixie‐Lee Esseltine is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 56 | |
| 2 | 4 | |
| 3 | 17 | |
| 4 | 81 | |
| 5 | 123 | |
| 6 | 232 | |
| 7 | 200 | |
| 8 | 73 | |
| 9 | 75 | |
| 10 | 42 | |
| 11 | 263 | |
| 12 | Phase I Trial of the Proteasome Inhibitor PS-341 in Patients With Refractory Hematologic Malignanciesbreakdown → | 586 |
About Dixie‐Lee Esseltine
Dixie‐Lee Esseltine is a scholar working on Hematology, Genetics and Dermatology, having authored 12 papers that have together received 1.8k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (6 papers), Protein Degradation and Inhibitors (4 papers) and Viral-associated cancers and disorders (3 papers). The work is most often cited by research in Hematology (1.1k citations), Oncology (817 citations) and Genetics (285 citations). Dixie‐Lee Esseltine has collaborated with scholars based in United States, France and Spain. Frequent co-authors include Paul G. Richardson, Jessica Anderson, Kenneth C. Anderson, Robert Z. Orlowski, Sagar Lonial, Stephanie Stahl, Beverly S. Mitchell, Mary Jo Lehman, Roberto Guerciolini and Thomas C. Shea. Their work appears in journals such as Journal of Clinical Oncology, Blood and The Lancet Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.